A Form 4 filed with the SEC shows Manufacturers Life Reinsurance Ltd, a 10%+ owner of John Hancock GA Senior Loan Trust, purchased 2,693,701 shares on 2026-08-31 in an open-market transaction. The insider paid $16.33 per share, putting the total outlay at $43,988,145.02.
Following the purchase, Manufacturers Life Reinsurance Ltd now holds 38,921,476 shares directly, reinforcing its position as a major stakeholder in the trust. Because this was an open-market buy rather than an option exercise or a grant, the insider used its own capital to acquire the stake at the prevailing market price, a detail that tends to draw more attention from filing-watchers than routine compensation-related transactions.
A Pattern of Insider Activity in JH-Affiliated Funds
This is not the first time an entity connected to John Hancock or Manulife has shown up in insider disclosures tracked by this site. Earlier in 2025, a related transaction was reported in our coverage of the Manulife Private Credit Plus Fund’s $9M purchase of JH Marathon ABL Fund shares. Taken together, these filings suggest ongoing capital commitments from Manulife-affiliated entities across several John Hancock-branded credit and loan vehicles, though each transaction stands as its own distinct disclosure.
John Hancock GA Senior Loan Trust does not carry a public ticker, which is typical for structured credit vehicles of this type. These funds are often held by institutional or affiliated parties, and 10%+ owner filings like this one are a useful window into how much capital insiders and related entities are committing to a fund’s underlying strategy at a given point in time.
Academic research on insider transactions has found that clustered or sizable insider buying can, in aggregate across many companies, correlate with stronger subsequent performance compared to insider selling. That said, this single filing is a disclosure of a completed transaction, not a signal to act on, and readers should treat it as one data point among many when evaluating any fund or company.
The size of this particular purchase, nearly $44 million, stands out even relative to other recent insider activity tracked on this site, including the smaller $3 million purchase highlighted in our report on the Calamos Aksia Fund. As always, additional context can be found in the underlying SEC filing linked with this article.
→ See all N/A coverage on WhoIsBuyingNow
Source: original SEC Form 4 filing.